Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM with respect to the Intrexon Patents under this Agreement;
Appears in 6 contracts
Samples: Exclusive Channel Partner Agreement (Intrexon Corp), Exclusive Channel Partner Agreement (Ziopharm Oncology Inc), Exclusive Channel Collaboration Agreement (Ziopharm Oncology Inc)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM AquaBounty with respect to the Intrexon Patents under this Agreement;
Appears in 5 contracts
Samples: Channel Collaboration Agreement, Exclusive Channel Collaboration Agreement (AquaBounty Technologies, Inc.), Exclusive Channel Collaboration Agreement (AquaBounty Technologies, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Oragenics with respect to the Intrexon Patents IP under this Agreement;
Appears in 5 contracts
Samples: Confidential Treatment (Oragenics Inc), Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Ampliphi with respect to the Intrexon Patents under this Agreement;
Appears in 4 contracts
Samples: Channel Collaboration Agreement (AmpliPhi Biosciences Corp), Collaboration Agreement (AmpliPhi Biosciences Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Synthetic with respect to the Intrexon Patents under this Agreement;
Appears in 3 contracts
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp), Collaboration Agreement (Synthetic Biologics, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Soligenix with respect to the Intrexon Patents under this Agreement;
Appears in 3 contracts
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp), Collaboration Agreement (Soligenix, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Genopaver with respect to the Intrexon Patents under this Agreement;
Appears in 2 contracts
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Histogenics with respect to the Intrexon Patents IP under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Histogenics Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Synthetic with respect to the Intrexon Patents IP under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Synthetic Biologics, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Adeona with respect to the Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Collaboration Agreement (Adeona Pharmaceuticals, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM OvaScience with respect to the Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (OvaScience, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM OvaXon with respect to the Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (OvaScience, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM NewCo with respect to the Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM Adeona with respect to the Intrexon Patents under this Agreement;; 26
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Adeona Pharmaceuticals, Inc.)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM JV with respect to the Intrexon Channel Technology, Intrexon IP, Intrexon Trademarks, and Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp)
Additional Intellectual Property Representations. (i) Intrexon possesses sufficient rights to enable Intrexon to grant all rights and licenses it purports to grant to ZIOPHARM BioLife with respect to the Intrexon Patents under this Agreement;
Appears in 1 contract
Samples: Exclusive Research Collaboration Agreement (Intrexon Corp)
